Mediherb Boswellia Complex 60 Tablets
Mediherb Boswellia Complex 60 Tablets

Boswellia Complex 60 Tablets

$109.95 AUD
View full range
Australian-owned • Independent • Trusted wellness
Practitioner-grade support. Always read the label and follow the directions for use.
Join Wellness Circle

Member pricing + shipping perks.

Shipping From $9.95 · Free over $200

Shipped with Australia Post — trackable and reliable. Our delivery success rate has been 98% on time over the last 90 days.

  • Free Shipping (tracked): 8–16 business* days — orders $200+
  • Standard (tracked): 5–8 business days — from $9.95
  • Express (tracked): 2-6 buisness days from $12.95
View Shipping Policy
View details

Joint Health and Inflammation Support

Boswellia Complex is a vegan-friendly herbal supplement that supports joint health and relieves inflammation. It contains a blend of Boswellia, Turmeric, Celery, and Ginger. This product is available for dispensing by healthcare practitioners only, and it's essential to read the label and follow the recommended usage instructions carefully. 


Boswellia serrata (Boswellia) gum oleoresin extract 277 mg (derived from dry gum oleoresin 1.9 g, standardised to boswellic acids 180 mg); Curcuma longa (Turmeric) rhizome extract 80 mg (derived from dry rhizome 2 g, standardised to curcuminoids 76 mg); Apium graveolens (Celery) fruit extract 2 mL (derived from dry fruit 1 g); Zingiber officinale (Ginger) rhizome extract 600 µL (derived from dry rhizome 300 mg).


1 tablet 2 – 4 times daily


Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycollate

  • No added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds, artificial sweeteners, colours or flavours. Vegan friendly.
  • Daily doses of dried Ginger in excess of 4 g are contraindicated in patients taking blood-thinning drugs or at increased risk of bleeding. Exercise caution.
  • Contraindicated in patients taking nifedipine.
  • Caution in patients taking crizotinib, tacrolimus, talinolol, and etoricoxib. Discontinue seven days prior to general anaesthesia.
  • If patient symptoms persist, seek additional professional advice.